These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 36092880)

  • 41. Pan-cancer analysis of cuproptosis regulation patterns and identification of mTOR-target responder in clear cell renal cell carcinoma.
    Long S; Wang Y; Chen Y; Fang T; Yao Y; Fu K
    Biol Direct; 2022 Oct; 17(1):28. PubMed ID: 36209249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cuproptosis in ccRCC: key player in therapeutic and prognostic targets.
    Lv Y; Li Q; Yin L; He S; Qin C; Lu Z; Chen H
    Front Oncol; 2023; 13():1271864. PubMed ID: 37965478
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Construction of cuproptosis-related gene signature to predict the prognosis and immunotherapy efficacy of patients with bladder cancer through bioinformatics analysis and experimental validation.
    Liu Z; Zhu F; Zhang P; Qian B; Liu W; Xiao Y; Chen N; He Q; Xiao J
    Front Genet; 2022; 13():1074981. PubMed ID: 36506302
    [No Abstract]   [Full Text] [Related]  

  • 44. The cuproptosis-related gene signature serves as a potential prognostic predictor for ovarian cancer using bioinformatics analysis.
    Sun X; Xu P; Zhang F; Sun T; Jiang H; Lu X; Zhang M; Li P
    Ann Transl Med; 2022 Sep; 10(18):1021. PubMed ID: 36267774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arecoline Is Associated With Inhibition of Cuproptosis and Proliferation of Cancer-Associated Fibroblasts in Oral Squamous Cell Carcinoma: A Potential Mechanism for Tumor Metastasis.
    Li J; Chen S; Liao Y; Wang H; Zhou D; Zhang B
    Front Oncol; 2022; 12():925743. PubMed ID: 35875097
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cuproptosis-related gene
    Wang T; Liu Y; Li Q; Luo Y; Liu D; Li B
    Front Immunol; 2022; 13():999823. PubMed ID: 36225932
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel cuproptosis-related lncRNA nomogram to improve the prognosis prediction of gastric cancer.
    Feng A; He L; Chen T; Xu M
    Front Oncol; 2022; 12():957966. PubMed ID: 36106123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pan-cancer analysis of cuproptosis-promoting gene signature from multiple perspectives.
    Ma J; Gong B; Zhao Q
    Clin Exp Med; 2023 Dec; 23(8):4997-5014. PubMed ID: 37318649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comprehensive Analysis of Cuproptosis-Related Genes in Prognosis and Immune Infiltration of Hepatocellular Carcinoma Based on Bulk and Single-Cell RNA Sequencing Data.
    Yang C; Guo Y; Wu Z; Huang J; Xiang B
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comprehensive Analysis of m
    Wu J; Hou C; Wang Y; Wang Z; Li P; Wang Z
    Int J Genomics; 2021; 2021():3803724. PubMed ID: 34631874
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel defined cuproptosis-related gene signature for predicting the prognosis of colon adenocarcinoma.
    Luo B; Lin J; Ni A; Cai W; Yu X; Wang M
    Front Oncol; 2022; 12():927028. PubMed ID: 36505872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification and validation of a novel cuproptosis-related lncRNA signature for prognosis and immunotherapy of head and neck squamous cell carcinoma.
    Xu QS; Shen ZZ; Yuan LQ
    Front Cell Dev Biol; 2022; 10():968590. PubMed ID: 36467424
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of cuproptosis-related gene signature to predict prognosis in lung adenocarcinoma.
    Lv Y; Xiao Y; Cui X; Luo H; Xu L
    Front Genet; 2022; 13():1016871. PubMed ID: 36313444
    [No Abstract]   [Full Text] [Related]  

  • 54. Cuproptosis-Related Ferroptosis genes for Predicting Prognosis in kidney renal clear cell carcinoma.
    Luo G; Wang L; Zheng Z; Gao B; Lei C
    Eur J Med Res; 2023 May; 28(1):176. PubMed ID: 37189176
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of cuproptosis-related signature with the prognosis of patients with head and neck squamous cell carcinoma.
    Li Y; Sun C; Gu F; Yue J; Huang X; Yuan B; Wang Y; Chen R
    J Biomol Struct Dyn; 2024 Jan; ():1-12. PubMed ID: 38279934
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
    Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
    BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel cuproptosis-related gene signature for overall survival prediction in patients with hepatocellular carcinoma.
    Yang F; Jiang S; Liu Y; Zhang T; Zhu C; Zhang L; Sang X; Lu X; Wei J; Deng K; Zheng Y; Xu Y
    Heliyon; 2022 Nov; 8(11):e11768. PubMed ID: 36468143
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of an Autophagy-Related Prognostic Signature for Clear Cell Renal Cell Carcinoma.
    Chen M; Zhang S; Nie Z; Wen X; Gao Y
    Front Oncol; 2020; 10():873. PubMed ID: 32547955
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of a m
    Chen J; Yu K; Zhong G; Shen W
    Cancer Cell Int; 2020; 20():157. PubMed ID: 32419773
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    Wang B; Liu B; Luo Q; Sun D; Li H; Zhang J; Jin X; Cheng X; Niu J; Yuan Q; Chen Y
    Transl Cancer Res; 2022 Jul; 11(7):2321-2337. PubMed ID: 35966310
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.